FDA
-
-
-
-
-
-
-
ICU Medical Announces Fourth Quarter 2025 Results and Provides Fiscal Year 2026 Guidance
-
-
-
-
-
-
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ICU Medical, Inc. – ICUI
-
-
-
-
-
-
-
ICU Medical Announces Fourth Quarter 2024 Results and Provides Fiscal Year 2025 Guidance
-
-
-
-
-
-
-
ICU Medical Issues a Voluntary Nationwide Recall of Aminosyn II 15%, An Amino Acid Injection, Sulfite Free IV Solution Due to the Presence of Particulate Matter
-
-
-
-
-
-
-
NanoString Appoints Elisha W. Finney to Board of Directors
325,893 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

